At present, it has been found that the CSNK2B variant leads to significant differences in epilepsy phenotypes in POBINDS cases So far, there have been no reports of CSNK2B related cases dying from seizures, indicating a lower risk of mortality from CSNK2B related epilepsy. The gene discussed is CSNK2B; the disease is epilepsy.